<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>13</Volume><Issue>2</Issue><PubDate PubStatus="epublish"><Year>2022</Year><Month>04</Month><Day>09</Day></PubDate></Journal><title locale="en_US">Pramlintide: An Amylin Analogue Protects Endothelial Cells against Oxidative Stress through Regulating Oxidative Markers and NF‑κb Expression</title><FirstPage>2613</FirstPage><LastPage>2613</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan,</affiliation></Author><Author><affiliation locale="en_US">Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2022</Year><Month>04</Month><Day>06</Day></PubDate></History><abstract locale="en_US">&lt;strong&gt;Background&lt;/strong&gt;: Oxidative stress has a prominent role in the pathogenesis of diabetes complications. Pramlintide is an injectional amylin analogue used for the treatment of type 1 and type 2 diabetic patients. The present investigation evaluated the effect of pramlintide against oxidative damage induced by hydrogen peroxide (H2 O2 ) in human umbilical vein endothelial cells (HUVECs). &lt;strong&gt;Methods&lt;/strong&gt;: Cell viability was assessed using 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide method. Hydroperoxides level, ferric reducing antioxidant power (FRAP), and expression of transcription factor NF‑κB were measured in HUVECs that pretreated with pramlintide and, then exposed to H2 O2 . &lt;strong&gt;Results&lt;/strong&gt;: Pramlintide significantly decreased the cytotoxicity caused by H2 O2 at the concentrations of 5 and 10 µg/mL. Pretreatment of HUVECs with pramlintide reduced hydroperoxides and increased FRAP value in intra‑ and extra‑cellular mediums at different concentration ranges compared with H2 O2 stimulated cells. Pramlintide (10 µg/mL) remarkably ameliorated the expression of NF‑κB gene after 1, 3 and 24 h exposure to H2 O2 . &lt;strong&gt;Conclusions&lt;/strong&gt;: Findings of the current investigation displayed that pramlintide may act as a protective against oxidative conditions in endothelial cells through modulation of oxidative markers and transcription factor NF‑κB.</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2613</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2613/717718453</pdf_url></Article></Articles>
